Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesHTR2A gene variation is involved in antidepressant treatment response
European Neuropsychopharmacology, 09/17/09
Lucae S et al. – Two serotonin 2A receptor SNPs recently reported to be associated with antidepressant treatment response in STAR|D were analyzed for association with treatment response in two independent Caucasian samples of patients with a Major Depressive Episode. In the combined sample SNP rs7997012 was significantly associated with remission after five weeks providing first replicative support for the initial finding, with, however, an inverse allelic association as compared to the STAR|D sample.
Related Articles
When starting an antidepressant, try either of these 2 drugs first
APCToday, 11/20/09
Relevance Score: 88%
Explaining Racial and Ethnic Differences in Antidepressant Use Among Adolescents
Medical Care Research and Review, 11/18/09
Relevance Score: 87%
The Role of Sodium Channels in the Mechanism of Action of Antidepressants and Mood Stabilizers
Current Drug Targets, 10/30/09
Relevance Score: 87%
Increase In Long-term Antidepressant Drug Use, UK Study Reveals
ScienceDaily, 10/26/09
Relevance Score: 87%
Study reveals an increase in long-term antidepressant drug use
EurekAlert, 10/23/09
Relevance Score: 87%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pregabalin-Induced Parkinsonism: A Case Report
Clinical Neuropharmacology, 12/16/09
Effective Treatment With Low-Dose Fluvoxamine for Obsessive-Compulsive Disorder After Neurosurgery: A Case Report
Clinical Neuropharmacology, 12/16/09
Fluoxetine Blocks Myotonic Runs and Reverts Abnormal Surface Electromyogram Pattern in Patients With Myotonic Dystrophy Type 1
Clinical Neuropharmacology, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor